Effectiveness of Siddha Formulations in Treating Breast Cancer: An Evidence-Based Case Series

Shanmugasundaram Gouthaman (1) , Roshni Saravanan (2) , Jayaprakash Narayanan (3) , Arputha Selvi A (4)
(1) Department of Surgical Oncology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education & Research (Deemed University), Porur, Chennai, Tamil Nadu, India, India ,
(2) Department of Human Genetics, Faculty of Bio-Medical Sciences, Technology and Research, Sri Ramachandra Institute of Higher Education & Research (Deemed University), Porur, Chennai, Tamil Nadu, India, India ,
(3) Scientific Advisory Committee, National Institute of Siddha, Chennai, Tamil Nadu, India, India ,
(4) Jaya Indian Medicine Pharmaceutical Pvt. Ltd, Chennai, Tamil Nadu, India, India

Abstract

Breast cancer is one of the top-ranked cancers affecting women in the world. Although there are approved standard regimens for treatment, due to toxicological side effects, there is a demand for novel anti-cancer drugs with minimal adverse effects leading to the emergence of Indian Systems of Medicine. Natural treatment modalities such as Siddha, Ayurveda and Unani are emerging and have been given gaining importance in recent times. They have been in vogue for centuries together and have shown better prognosis over a period of time with lesser toxicity and admiring oncological results. The presentation is an evidence-based report on the cure of breast cancer using Siddha chemotherapeutic formulations.

Full text article

Generated from XML file

References

Baskaran, J., Gnanamani, A., Stanley, V., Stanley, S. A. 2017. Studies on the Anticancer Potential (GI50) of the Siddha Formulation, Rasagenthi Mezhugu on Human Cell Lines. Journal of Chemical and Pharmaceutical Research, 9(10):254–257.

Deshmukh, V., Kulkarni, A., Bhargava, S., Patil, T., Ramdasi, V., Gangal, S., Sardeshmukh, S. 2014. Effectiveness of combinations of Ayurvedic drugs in alleviating drug toxicity and improving quality of life of cancer patients treated with chemotherapy. Supportive Care in Cancer, 22(11):3007– 3015.

Diwanay, S., Chitre, D., Patwardhan, B. 2004. Immuno protection by botanical drugs in cancer chemotherapy. Journal of ethnopharmacology, 90(1):49–55.

Gladys, R., Arasi, R.K., Elangovan, S., Mubarak, H. 2013. Screening of siddha medicinal plants for anti-cancer activity - A review. J Appl Pharm Sci, 3(8):176–182.

James Vaidyan 2018. Indian treatment for Leukemia and other cancers. J Cancer Science Therapy, 10:1.

Joseph, C.D., Praveenkumar, V., Kuttan, G., Kuttan, R. 1999. Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study. Journal of experimental & clinical cancer research: CR, 18(3):325–329.

Lekha, G.S., Aparna, S., Kasirajan, N., Kanagarajan, A. 2018. Diagnosis and Treatment of Cancer–Siddha Perspective. J Res Sid Med, 1(1):3–14.

Liao, G., Apaya, M.K., Shyur, L.F. 2013. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Alternat Med, 2013:437948.

Malvia, S., Bagadi, S.A., Dubey, U.S., Saxena, S. 2017. Epidemiology of breast cancer in Indian women. Asia-Pacific Journal of Clinical Oncology, 13(4):289–295.

Metri, K., Bhargav, H., Chowdhury, P., Koka, P. S. 2013. Ayurveda for chemo-radiotherapy induced side effects in cancer patients. Journal of stem cells, 8(2):115–129.

Mondal, J., Panigrahi, A.K., Khuda-Bukhsh, A.R. 2014. Conventional chemotherapy: problems and scope for combined therapies with certain herbal products and dietary supplements. Austin J Mol Cell Biol, 1(1):10.

Olaku, O., Zia, F., Santana, J.M., White, J.D. 2013. The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India. Integrative cancer therapies, 12(5):385–392.

Poornima, P., Efferth, T. 2016. Ayurveda for Cancer Treatment. Med Aromat Plants (Los Angel), 5(5):1– 3.

Ranga, R.S., Girija, R., Sathishkumar, S., Akbarsha, M.A., Thirugnanam, S., Rohr, J., Chendil, D. 2004. Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer. Cancer chemotherapy and pharmacology, 54(1):7–15.

Riyasdeen, A., Periasamy, V., Paul, P., Alshatwi, A., Akbarsha, M. 2012. Chloroform Extract of Rasagenthi Mezhugu, a Siddha Formulation, as an Evidence-Based Complementary and Alternative Medicine for HPV-Positive Cervical Cancers. Evid Based Complement Alternat Med, 2012(136527).

Shukla, S., Saraf, S. 2011. Fundamental aspect and basic concept of siddha medicines. Systematic Reviews in pharmacy, 2(1):48–54.

Sowmyalakshmi, S.E., Alam, M.N., Akbarsha, M.A., Thirugnanam, S., Rohr, J., Chendil, D. 2005. Investigation on Semecarpus Lehyam—a Siddha medicine for breast cancer. Planta, 220(6):910– 918.

Tagliaferri, M., Cohen, I., Tripathy, D. 2001. Complementary and alternative medicine in early-stage breast cancer (2001, February). In Seminars in Oncology. WB Saunders, 28(1):121–134.

Tharakan, S.T., Kuttan, G., Kuttan, R., Kesavan, M., Rajagopalan, K. 2010. Toxicity Studies of Sidha Medicine-Rasagandhi Mezhugu. The open toxicology journal, 4(1):43–50.

WHO 2018. GLOBOCAN - Global Cancer Observatory. World Health Organization. Accessed on: 04 March 2018.

Authors

Shanmugasundaram Gouthaman
gouthamonco1@gmail.com (Primary Contact)
Roshni Saravanan
Jayaprakash Narayanan
Arputha Selvi A
Shanmugasundaram Gouthaman, Roshni Saravanan, Jayaprakash Narayanan, & Arputha Selvi A. (2021). Effectiveness of Siddha Formulations in Treating Breast Cancer: An Evidence-Based Case Series. International Journal of Research in Pharmaceutical Sciences, 12(2), 1546–1551. Retrieved from https://ijrps.com/home/article/view/285

Article Details

Most read articles by the same author(s)

No Related Submission Found